Plain-English translation of NCT06490744 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers at University Hospital in Strasbourg are studying how COVID-19 affects people who have received lung transplants. This is a retrospective study, meaning researchers will review the medical records of patients who had COVID-19 between 2020 and 2022 to track changes in how well their transplanted lungs worked during and after the infection.
Lung transplant patients are at higher risk of severe COVID-19 because they take medications to suppress their immune system (to prevent rejection of the transplant). Doctors want to understand whether the infection itself, the severity of lung damage, or other factors determine how well transplanted lungs function after a COVID-19 infection—and whether newer treatments like vaccines helped protect these vulnerable patients.
This is not an active treatment study—you would not attend visits or take new medications. Instead, researchers would review your existing medical records from your time in the hospital with COVID-19 and your follow-up lung transplant care. They will track how your lung function changed during the infection and in the months afterward to better understand the long-term impact.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
France